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Abstract
Background: Intact myelin, which normally surrounds axons, breaks down in Wallerian degeneration following
axonal injury and during neurodegenerative diseases such as multiple sclerosis. Clearance of degenerated myelin by
phagocytosis is essential since myelin impedes repair and exacerbates damage. CR3 (complement receptor-3) is a
principal phagocytic receptor in myelin phagocytosis. We studied how tyrosine kinase Syk (spleen tyrosine kinase)
and cofilin control phagocytosis of degenerated myelin by CR3 in microglia and macrophages. Syk is a
non-receptor tyrosine kinase that CR3 recruits to convey cellular functions. Cofilin is an actin-depolymerizing protein
that controls F-actin (filamentous actin) remodeling (i.e., disassembly and reassembly) by shifting between active
unphosphorylated and inactive phosphorylated states.
Results: Syk was continuously activated during prolonged phagocytosis. Phagocytosis increased when Syk activity
and expression were reduced, suggesting that normally Syk down regulates CR3-mediated myelin phagocytosis.
Levels of inactive p-cofilin (phosphorylated cofilin) decreased transiently during prolonged phagocytosis. In contrast,
p-cofilin levels decreased continuously when Syk activity and expression were continuously reduced, suggesting
that normally Syk advances the inactive state of cofilin. Observations also revealed inverse relationships between
levels of phagocytosis and levels of inactive p-cofilin, suggesting that active unphosphorylated cofilin advances
phagocytosis. Active cofilin could advance phagocytosis by promoting F-actin remodeling, which supports the
production of membrane protrusions (e.g., filopodia), which, as we also revealed, are instrumental in myelin
phagocytosis.
Conclusions: CR3 both activates and downregulates myelin phagocytosis at the same time. Activation was
previously documented. We presently demonstrate that downregulation is mediated through Syk, which advances
the inactive phosphorylated state of cofilin. Self-negative control of phagocytosis by the phagocytic receptor can
be useful in protecting phagocytes from excessive phagocytosis (i.e., “overeating”) during extended exposure to
particles that are destined for ingestion.
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Background
Intact myelin, which normally surrounds axons, breaks
down during Wallerian degeneration following traumatic
injury to axons [1-3] and during neurodegenerative dis-
eases such as multiple sclerosis [4]. Degenerated myelin
thus formed impedes repair and exacerbates damage by
arresting regeneration [5-7], inhibiting remyelination [8]
and advancing production of membrane attack com-
plexes [9,10]. Therefore, rapid clearance of the degener-
ated myelin is critical for repair of the injured nervous
system. Regarding this, it is important to elucidate the
mechanisms that regulate degenerated myelin phagocyt-
osis. We focused in this study on how Syk and cofilin
regulate the myelin phagocytosis that CR3 (complement
receptor-3; αMβ2 integrin) mediates in primary microglia
and macrophages; the term "myelin" will replace "degen-
erated myelin" from here onward for simplicity.
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The principal phagocytic receptors for myelin on
macrophages and microglia are CR3, SRA (scavenger
receptor-AI/II), and Fcγ [11-14]. CR3 functions both as a
C3bi/opsonic and unopsonic receptor for C3bi-opsonized
and unopsonized myelin, respectively. Unopsonic SRA
primarily mediates phagocytosis of unopsonized myelin.
However, Fcγ, but not CR3 and SRA, requires prior
opsonization of myelin by anti-myelin Abs. We studied
myelin phagocytosis by CR3 and SRA in the absence of
anti-myelin Abs.
Syk is a non-receptor tyrosine kinase that phagocytic
receptors Fcγ, CR3, and Dectin-1 recruit upon their acti-
vation [15-19]. However, Syk may or may not activate
phagocytosis depending on the type of phagocyte, the
identity of the phagocytic receptor, and the nature of the
ingested particle [20-24]. It is important, therefore, to
study each phagocyte, receptor, and phagocytosed par-
ticle combination on its own.
Cofilin/ADF (actin depolymerizing factor) is a family
of proteins that controls F-actin remodeling and thereby
the production of membrane protrusions (e.g., filopodia
and lamelopodia). In mice, cofilin-1 is expressed in most
cells, cofilin-2 in muscle, and ADF in epithelial and
nerve cells [25]. Cofilin can regulate myelin phagocyt-
osis by controlling F-actin remodeling and filopodia
production since filopodia are involved in myelin phago-
cytosis (Figure 1). First, filopodia engulf myelin as they
extend, and then, filopodia pull myelin into phagocytes
as they retract. Protrusion of membranes requires local
remodeling of F-actin [26-28]. In turn, retraction of
membrane protrusions is aided by contraction, which is
based on interactions between actin and non-muscle
myosin [29]. Active unphosphorylated cofilin advances
remodeling by cutting of F-actin into G-actin mono-
mers. Then, severed F-actin may protrude cell mem-
branes as it reassembles and grows. The transitions of
cofilin between inactive and active states in inflamma-
tory cells are mainly through phosphorylation and
dephosphorylation.
We document in this study that CR3 activated Syk,
which in turn downregulated CR3-mediated phagocyt-
osis of C3bi-opsonized and unopsonized myelin in CNS
microglia and bone marrow-derived macrophages by
advancing the inactive phosphorylated state of cofilin
(Figure 1). Syk-dependent downregulation of phagocyt-
osis and Syk-dependent control of cofilin activation
have not been reported previously. These observations
suggest a novel mechanism by which CR3 can both ac-
tivate and downregulate myelin phagocytosis in parallel.
This self-negative control of phagocytosis by CR3 can
be useful in protecting phagocytes from excessive
phagocytosis during extended exposure to degenerated




Wild-type BalbC and C57BL6 mice (Harlan, Israel), and
BalbC mice lacking SRAI/II (SRAI/II−/−) or C57BL6 mice
lacking αM/CD11b subunit of CR3 (CR3
−/−) were used
and handled in accordance with the National Research
Council’s guide for the care and use of laboratory ani-
mals and the approval of the institutional committee.
Primary microglia were isolated from neonate mice
brains [13]. In brief, brains were stripped of their
Figure 1 CR3 both activates and downregulates myelin
phagocytosis – a schematic representation of the working
hypothesis and experimental design. Binding of myelin to CR3
initiates structural changes characteristic of phagocytosis (marked by
ellipses). Filopodia-like membrane protrusions engulf myelin as they
extend and then pull myelin in as they retract. Production of
filopodia depends on F-actin remodeling, which active
unphosphorylated cofilin advances (#) and inactive p-cofilin impedes
(?) [26-28]. Therefore, phagocytosis is expected to be reduced when
cofilin is inactivated by shifting the balance from cofilin to p-cofilin
through activation of LIMK and/or TESK, for example, by RhoA and
ROCK, and/or downregulation of phosphatases SSH and CIN. CR3
downregulates phagocytosis by activating Syk, which in turn
advances the inactive phosphorylated state of cofilin. How Syk
promotes cofilin inactivation is yet to be determined. CR3 activates
myelin phagocytosis by activating K-Ras and its downstream
effectors in a galectin-3-dependent manner [30-33]. Subsequently,
retraction of filopodia is aided by contraction that Ca+2-calmodulin-
dependent MLCK (myosin light chain kinase) activates and F-actin
and non-muscle myosin carry out [34]. Not all possible interactions
are shown.
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meninges, enzymatically dissociated, cells plated on
poly-L-lysine-coated flasks for 1 week, replated for 1 to
2 h on bacteriological plates, and non-adherent cells
washed away. The vast majority of adherent cells (over
95%) are microglia judged by morphology and positive
immunoreactivity to the murine-specific monocyte,
macrophage, and microglia marker F4/80, and the acti-
vation markers galectin-3/MAC-2 and CR3. Microglia
were propagated by incubation in medium containing
10% conditioned medium by the L-cell line, which pro-
duces M-CSF.
Primary peritoneal macrophages were harvested in
cold DMEM/F12 3 to 4 days after intraperitoneal injec-
tion of 1.5 ml of 3 % thioglycollate (Difco, USA), plated
in the presence of 10% heat-inactivated FCS in 96-well
culture plates (Nunc International, USA) for 2 h, and
non-adherent cells washed away. The remaining adhered
cells are macrophages since they express F4/80, galectin-
3/MAC-2, and CR3 [12].
Myelin isolation
Myelin was isolated from mice brains as previously
described [35].
C3bi-opsonization was carried out by pre-incubating
myelin in 50% fresh mouse or rat serum in DMEM/F12
for 40 min at 37° C, followed by washing in serum-free
media as previously described [34,36]. Levels of phago-
cytosis were the same whether mouse or rat sera were
used, indicating similar opsonization efficiency by the
two. Additionally, experiments that were performed in
the presence of 10% HI (heat inactivated)-rat serum,
10% HI-mouse serum, 10% HI-FCS, or 0.1% delipidated
BSA did not differ, indicating that heat inactivation of
the complement system was effective in all sera. We
used, therefore, mostly rat serum, which is easier to ob-
tain in the quantities required to opsonize myelin, and
HI-FCS as supplement in the phagocytosis assays. The
efficiency of C3bi-opsonization was tested in each indi-
vidual experiment by validating that levels of phagocyt-
osis of C3bi-opsonized myelin are about two fold higher
than those of unopsonized myelin.
Myelin phagocytosis
Microglia or macrophages were plated in 96-well tissue
culture plates at a density that minimizes cell-cell con-
tact (2.5 × 104/well) in the presence of DMEM/F12 sup-
plemented with 10% heat inactivated (HI) rat serum,
10% HI mouse serum, 10% HI-FCS, or 0.1 % delipidated
BSA (Sigma-Aldrich, Israel), thus in the absence of ex-
ternally provided complement. Phagocytes were left to
rest overnight, washed, and myelin was added for the
indicated times. Then unphagocytosed myelin was
washed out and levels of phagocytosis quantified. At this
time all remaining myelin has already been internalized/
phagocytosed [34]. When phagocytosis was assayed in
the presence of Syk inhibitors, phagocytes were pre-
incubated in the presence of either SYK-inhibitor or
piceatannol (Calbiochem, USA), or control/vehicle for
15 min, and phagocytosis assayed thereafter in the con-
tinued presence of inhibitor/vehicle.
ELISA assay to quantify myelin phagocytosis is based
on the detection of the myelin-specific MBP (myelin
basic protein) in lysates of phagocytes [35]. Since MBP is
unique to PNS and CNS myelin, and is not produced by
phagocytes, MBP levels detected in cytoplasm are pro-
portional to levels of phagocytosed myelin. In brief, after
non-phagocytosed myelin is washed away, phagocytes
are lysed, lysates transferred to high-protein absorbance
plates (Nalge Nunc International, USA), and levels of
MBP determined by ELISA using rat anti-MBP (Serotec,
Oxford, UK). We determined previously that more than
95% of the detected MBP arises from phagocytosed/
internalized myelin [35]. We further verified the validity
of this phagocytosis assay by testing the ability to detect
inhibition of myelin phagocytosis by cytochalasin-D [36].
Generation of microglia with stable reduced Syk and
cofilin expression
Reduction of Syk expression was achieved through lenti-
viral infection of wild-type BalbC microglia with short
hairpin RNAs directed against mouse Syk mRNA using
pLKO.1 puro plasmids (Sigma-Aldrich, Israel). The shRNA
sequence selected in the Syk cDNA coding sequence
was 5'CGGCGAAGGGAAAGTATTGCACTACTCGAG
TAGTGCAATACTTTCCCTTCGTTT3'. The plasmid
was transfected into a 293 T-based packaging cell line,
and the resulting culture supernatant was used for lenti-
viral infection of microglia. Infected microglia were
selected on the basis of their resistance to puromycin
(Sigma-Aldrich, Israel) brought by the pLKO.1 plasmid,
and their level of Syk protein expression was monitored by
immunoblotting. As control, microglia were infected in a
similar way with the shRNA sequence 5'CTTACGCTGAG
TACTTCGA-3' against the non-target firefly Luciferase
gene (a gift from Dr. I. Ben-Porath).
Immunoblotting
Phagocytes were washed in PBS and lysed by incubation
in ice-cold lysis buffer (Tris-HCL 1 M, pH 7.5, MgCl2 1
M, NaCl 4 M, 0.5 % NP-40, 0.1 % DTT, and 0.1 % NaVa)
supplemented with protease and phosphatase inhibitor
cocktail (Sigma-Aldrich, Israel), cellular debris was
removed by centrifugation, and total protein determined
using Bradford reagent (Sigma-Aldrich, Israel). Equal
protein content lysates were separated on 10% SDS-
PAGE to detect Syk and 12% SDS-PAGE to detect cofi-
lin. Proteins were blotted to nitrocellulose membranes,
blocked with 10% non-fat milk or 5% BSA in TBS
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(Tris-buffered saline) for 1 h at RT, incubated over
night at 4° C in the presence of primary Abs rabbit anti-
cofilin, rabbit anti-p-cofilin-1 and rabbit anti-Syk (Santa
Cruz Biotechnology, USA), rabbit anti-p-Syk (Cell Sig-
naling, USA), and mouse anti-actin mAb (MP Biomedi-
cals, USA). Blots were washed with TBST, and
incubated with respective secondary Abs goat anti-
rabbit and goat anti-mouse conjugated to HRP (Jackson
ImmunoReserach, USA) for 40 min at RT. Proteins
were visualized with EZ-ECL kit for HRP detection (Beit
Haemek, Israel). The intensities of immunoblot bands
were determined by TINA software, and quantification
was carried out as indicated in the figure legends.
Confocal fluorescence microscopy and time-lapse
cinematography
Myelin was pre-labeled by DiIc18 (Molecular Probes).
Then 1 μl of DiIc18 stock solution (5 mM in DMSO) was
added to 1 ml of myelin for 15 min at 37°C; myelin
washed (× 3 in culture medium) and then added to
macrophages. Macrophage plasma membrane was labeled
by dye RH237 (N-(4-sulfutyl)-4-(6-(p-dibutylamynophenyl)
hexatrenyl) pyridinium, inner salt (Molecular Probes). A
stock solution of 10-mM RH237 in ethanol was diluted
before use in culture medium to a final concentration of
0.5 μM. Images were taken in the continuous presence
of the dye. Therefore, some of the myelin, which was
pre-labeled by DiIc18, acquired some of the RH237. Ca+2
sensor Fluo-4 (Molecular Probes) was used to image the
cytoplasm of macrophages by imaging intracellular Ca+2.
Macrophages were incubated in Fluo-4/AM solution
(50 μg Fluo-4/AM dissolved in 10 μl DMSO to which
500 μl culture medium and 10 μl of 1 μg/μl pluronic acid
were added) for 40 min and then washed (× 3 in culture
medium).
The system used for confocal imaging consisted of an
Olympus microscope IX70 and a Bio-Rad Radiance
2000/AGR-3 confocal imaging system. RH237 was
excited at 514 nm (argon laser) and emitted fluorescence
collected by a 660-nm low-pass filter. DiIc18 was excited
at 543 nm (green HeNe laser) and emitted fluorescence
collected at 555–625 nm. Fluo-4 was excited at 488 nm
(argon laser) and emitted fluorescence collected at 500-
530 nm. The argon laser excitation intensity was usually
lowered to 5-10%. The pinhole was set to 1.6 to 2.5 mm.
A single optical slice was continuously but sequentially
scanned for DiIc18, RH237, and Fluo-4 (each lasting 9 s).
Images were collected and processed using LaserSharp,
LaserPix, and LaserVox (BioRad software).
Media products
Media products DMEM, DMEM/F12, FCS, HI-FCS,
gentamycin sulfate, and L-glutamine were obtained from
Biological Industries (Beit-Haemek, Israel).
Statistical analysis
Mann-Whitney and one- and two-way ANOVA analyses
were carried out as indicated in the figure legends.
Results
Syk is activated during phagocytosis of degenerated
myelin
Phagocytosis of myelin in the absence of anti-myelin
Abs is mediated jointly by CR3 and SRA, albeit two to
four fold more by CR3 than SRA [13]. Taken that Syk is
activated by phosphorylation during CR3-mediated Syk-
depended functions [15,16], we tested whether Syk is
also phosphorylated during myelin phagocytosis in wild-
type BalbC microglia and microglia infected with the
non-target luciferase-shRNA that were used in
Figure 2 Syk is phosphorylated during phagocytosis of
C3bi-opsonized myelin. (A) Total (T) and phospho (p) Syk levels
were determined by immunoblot analysis in lysates of wild-type and
control Con-Luc microglia before (0 min), and after 10 and 30 min of
phagocytosis. (B) The ratio p/T at 10 and 30 min was calculated
for each microglia type as percentage of p/T in respective
non-phagocytosing phagocytes (i.e., at 0 min), which was defined as
100%. Averages ± SEM of individual experiments, each performed in
triplicates, are given. Significance of difference by one-way ANOVA
and the Dunnet post test is *** p< 0.001. The immunoblot in (A) is
from control Con-Luc microglia. Data in (B) were obtained from
wild-type (squares) and Con-Luc (circles) microglia.
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subsequent experiments as control (Con-Luc) for micro-
glia that were infected with Syk-shRNA. Levels of p-Syk
(phosphorylated Syk) increased substantially for the en-
tire 30-min period of phagocytosis tested, indicating that
Syk was continuously activated during prolonged phago-
cytosis (Figure 2).
Syk down-regulates CR3-mediated myelin phagocytosis
We examined next how Syk regulates myelin phagocytosis
by analyzing how two distinct inhibitors of Syk affected
phagocytosis. The inhibitor “SYK inhibitor" [37] augmented
phagocytosis of C3bi-opsonized and unopsonized myelin,
which is mediated jointly by CR3 and SRA in wild-type
BalbC microglia and by CR3 without SRA in BalbC SRA−/−
microglia (Figure 3A). SYK inhibitor augmented phagocyt-
osis of C3bi-opsonized and unopsonized myelin by CR3
and SRA combined in wild-type C57BL microglia but pro-
duced inhibition of phagocytosis by SRA without CR3 in
C57BL CR3−/− microglia only at 1 μM (Figure 3B). Finally,
SYK inhibitor augmented phagocytosis of C3bi-opsonized
and unopsonized myelin in wild-type BalbC and C57BL
macrophages (Figure 3C). Taken together, SYK-inhibitor
augmented phagocytosis of C3bi-opsonized and unopso-
nized myelin by CR3, but not by SRA. In contrast to aug-
mentation by SYK inhibitor, phagocytosis of C3bi-
opsonized myelin was reduced in wild-type BalbC and
C57BL microglia by piceatannol, which was frequently used
by others (e.g., [38-40], as an inhibitor of Syk (Figure 3D).
Figure 3 SYK-inhibitor augments CR3-mediated phagocytosis of C3bi-opsonized and unopsonized myelin in microglia and
macrophages. SYK inhibitor augmented phagocytosis of C3bi-opsonized (C3bi-op) and unopsonized (unop) myelin in (A) wild-type BalbC (BC)
and SRA−/− microglia, (B) wild-type C57BL (C57) but not CR3−/− microglia, and (C) wild-types BalbC and C57BL macrophages. (D) Piceatannol
inhibited phagocytosis of C3bi-opsonized myelin by wild-type BalbC and C57BL microglia. Levels of phagocytosis that were determined after 30
and 60 min of exposure to myelin were similar and thus combined. Phagocytosis of C3bi-opsonized and unopsonized myelin in control/vehicle
(Con) was each defined as 100%. Phagocytosis at indicated concentrations of either SYK inhibitor or piceatannol was calculated as percentage of
respective control. Averages ± SEM of six to ten experiments, each performed in triplicates, and levels of significance by one-way ANOVA and the
Dunnett post test are: * p< 0.05, ** p< 0.01, *** p< 0.001. In (A) and (C), p< 0.001 for all values at 5 μM and 10 μM. In (D), p< 0.05 for all values
at 25 μM and p< 0.01 for all values at 50 μM and 75 μM.
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The opposing effects that the two inhibitors of Syk
produced did not allow us to determine whether Syk
activated or downregulated myelin phagocytosis. We
addressed this issue further by examining how phagocyt-
osis is affected after reducing Syk expression in phago-
cytes. Syk was knocked down (Syk-KD) by lentiviral
infection with Syk-shRNA in wild-type BalbC microglia
(Figure 4A and B). Consequently, phagocytosis of C3bi-
opsonized and unopsonized myelin was augmented
(Figure 4C), suggesting that normally Syk downregulates
this phagocytosis. Thus, augmentation in Syk-KD micro-
glia corresponded to augmentation by SYK inhibitor and
not to inhibition by piceatannol, indicating that SYK in-
hibitor and not piceatannol is Syk-specific in our assay
system. Therefore, SYK inhibitor and not piceatannol
was used to inhibit Syk activity pharmacologically in
subsequent experiments. Of note, also others questioned
the specificity of piceatannol towards Syk in some cell
types; see Discussion and [38-40].
Filopodia like membrane protrusions are involved in
myelin phagocytosis
Syk could downregulate CR3-mediated myelin phagocyt-
osis by affecting elements of cytoskeleton that control
phagocytosis. Since phagocytosis may require engulfment
of myelin by membrane protrusions, Syk could downregu-
late phagocytosis by impeding cofilin-dependent produc-
tion of membrane protrusions. We addressed this issue by
examining first if membrane protrusions are at all involved
in myelin phagocytosis. Phagocytosis was monitored live
by fluorescence confocal microscopy. Phagocytes pro-
duced filopodia-like membrane protrusions that engulfed
Figure 4 Phagocytosis of C3bi-opsonized and unopsonized myelin is augmented in Syk knocked-down (Syk-KD) microglia.
(A) Immunoblot of Syk and actin in wild-type BalbC (BC), control (Con-Luc), and Syk-KD microglia. (B) Quantitation of Syk levels based on (A).
Syk/actin ratio in BalbC and Syk-KD microglia was calculated as percentage of Syk/actin in control Con-Luc microglia, which was defined as
100%. Values of individual experiments, averages ± SEM, and significance of differences by double-tailed Mann-Whitney is *** p< 0.001.
(C) Phagocytosis of C3bi-opsonized (C3bi-op) and unopsonized (unop) myelin by Syk-KD and control Con-Luc microglia. Levels of phagocytosis
that were determined after 30 and 45 min of exposure to myelin were similar and thus combined. Phagocytosis by Syk-KD microglia was
calculated as percentage of phagocytosis by control Con-Luc microglia, which was defined as 100%. Values of individual experiments,
each performed in triplicates, averages ± SEM, and significance of differences by double-tailed Mann-Whitney is *** p< 0.001.
Figure 5 Filopodia engulf and then pull myelin into phagocyte. Successive steps during phagocytosis of a myelin particle by a wild-type
BalbC macrophage. (A) Arrows mark a filopodium-like structure (green and red) that engulfs a myelin particle (purple). Then (B to D), the
filopodium retracts, pulling the myelin into the phagocyte. Phagocytosis was monitored continuously by confocal fluorescence microscopy at a
single plane of focus. The macrophage cytoplasm was visualized by Ca+2 indicator Fura-4 (green), macrophage cell membrane by RH237 (red),
and myelin by DiIc18 (blue). However, RH237 that was initially localized to the macrophage plasma membrane diffused out and became
incorporated into myelin that turned purple (blue + red). Bar: 5 μm.
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myelin at initial stages of phagocytosis (Figure 5A). Then,
filopodia pulled myelin into phagocytes as they retracted
(Figure 5B, C and D).
Syk down-regulates cofilin activation by advancing the
inactive phosphorylated state of cofilin during myelin
phagocytosis
Active unphosphorylated cofilin promotes whereas in-
active p-cofilin impedes protrusion of membranes [26-28].
Since filopodia-like membrane protrusions engulfed
myelin at initial stages of phagocytosis (Figure 5), a po-
tential mechanism through which Syk could downregu-
late myelin phagocytosis is by advancing the inactive
phosphorylated state of cofilin. If this is the case, then
Syk-KD and Syk-inhibited microglia that phagocytose
more are expected to display lower levels of inactive
p-cofilin (see Figure 1). Indeed, this was the case after
45 min of phagocytosis (Figure 6A and B). Further,
initial levels of p-cofilin were about 20 % lower in
non-phagocytosing Syk-KD microglia than in non-
phagocytosing control microglia (Figure 6C and D).
Then, after 10 min of phagocytosis, p-cofilin levels were
reduced down to about 65% of initial control levels in both
Syk-KD and control microglia. However, as phagocytosis
continued and reached 30 min, p-cofilin levels decreased
further down to about 50% of initial levels in Syk-KD
microglia but returned towards initial levels in control
microglia. Therefore, prolonged phagocytosis by control
microglia was associated with a transient decrease in in-
active p-cofilin, thus transient activation of cofilin. In con-
trast, augmented prolonged phagocytosis by Syk-KD and
Syk-inhibited microglia was associated with a continuous
decrease in inactive p-cofilin, thus continuous activation of
cofilin. Further, levels of phagocytosis and levels of p-cofilin
displayed inverse relationships in Syk-KD and Syk-inhibited
phagocytes.
We predicted and then tested the following based on
the inverse relationships between levels of phagocytosis
and levels of p-cofilin. First, Syk-KD and control micro-
glia will phagocytose about the same after 10 min since
the two displayed similar levels of p-cofilin at that time.
Second, Syk-KD microglia will phagocytose more than
control microglia after 30 min since Syk-KD microglia
displayed substantially lower levels of p-cofilin than con-
trol microglia at that time. Indeed, these predictions
were confirmed as Syk-KD and control microglia phago-
cytosed about the same after 10 min, whereas Syk-KD
microglia phagocytosed considerably more than control
microglia after 30 min (Figure 6E and F).
Discussion
We document in this study that CR3 downregulates the
phagocytosis of C3bi-opsonized and unopsonized myelin
in CNS microglia and bone marrow-derived macrophages
through Syk, which advances the inactive phosphorylated
state of cofilin. We previously documented that CR3 acti-
vates this phagocytosis through K-Ras and its downstream
effector molecules in a galectin-3-dependent manner.
Taken together, CR3 can both activate and downregulate
myelin phagocytosis at the same time (Figure 1).
Syk down-regulates CR3-mediated phagocytosis of
C3bi-opsonized and unopsonized myelin
Syk-dependent downregulation of CR3- but not SRA-
mediated phagocytosis of C3bi-opsonized and unopso-
nized myelin is suggested by the following observations.
First, Syk was continuously phosphorylated, thus con-
tinuously activated, during prolonged phagocytosis.
Then, SYK inhibitor augmented phagocytosis in SRA−/−
microglia where phagocytosis is CR3-dependent and
SRA-independent, but not in CR3−/− microglia, in which
phagocytosis is SRA-dependent and CR3-independent.
In accord, SYK inhibitor augmented myelin phagocyt-
osis, which is mediated by CR3 and SRA combined in
wild-type BalbC and C57BL microglia and macrophages,
and in Syk-KD microglia that express reduced Syk levels.
Previous studies documented that Syk either activated
or did not regulate phagocytosis at all depending on the
type of phagocyte, the identity of the phagocytic recep-
tor, and the nature of the ingested particle. Syk activated
FcγR-mediated phagocytosis of IgG-opsonized erythro-
cytes in macrophages [20,21], and Syk activated CR3-
mediated phagocytosis of C3bi-opsonized zymosan in
transformed HL60 cells [22], but not in primary macro-
phages [21]; finally, Syk activated Dectin-1-mediated
phagocytosis of unopsonized zymosan in NIH 3T3 fibro-
blasts transfected with Dectin-1 [24], but neither in pri-
mary macrophages nor the macrophage cell line
RAW164.7 [23,24]. We presently add the novel category
of Syk-dependent downregulation phagocytosis, namely
the phagocytosis of C3bi-opsonized and unopsonized
myelin by CR3 in primary microglia and macrophages.
Our present findings suggest further that the occurrence
of Syk-dependent downregulation of myelin phagocyt-
osis is also determined by the identity of the phagocytic
receptor since SYK-inhibitor augmented myelin phago-
cytosis by CR3 and not by SRA.
The two pharmacological inhibitors of Syk that we
used produced contrasting effects, SYK-inhibitor aug-
mented whereas piceatannol inhibited myelin phagocyt-
osis. Of the two, SYK inhibitor (IC50 value of 15nM)
[37] is Syk-specific in our assay system since knocking
down Syk expression augmented myelin phagocytosis, as
did SYK inhibitor. Inhibition by piceatannol can be
explained on two grounds. First, our previous observa-
tions showed that PKA (protein kinase-A), PKC (protein
kinase-C), and MLCK (myosin light chain kinase) acti-
vated myelin phagocytosis (Figure 1 and [30-33]). Second,
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Figure 6 Cofilin is continuously activated during prolonged phagocytosis when Syk is either inhibited or its expression reduced, but
transiently activated during normal phagocytosis. (A) Quantitation of phospho-cofilin-1 (p-cofilin) and total (T) cofilin after 45 min of
phagocytosis by Syk-KD and Syk-inhibited (Syk-in) microglia and their respective controls (Con-Luc and Con SYK-in) based on (B) immunoblot
analysis. In (A), p/T ratio in Syk-KD and Syk-inhibited microglia was calculated as percentage of p/T in their respective controls that were defined
as 100% each. Values of individual experiments, averages ± SEM, and significance of difference by double-tailed Mann-Whitney is ***p< 0.001.
(C) Quantitation of p/T before (0 min) and after 10 and 30 min (min) of phagocytosis based on (D) immunoblot analysis. In (C), p/T in non-
phagocytosing Con-Luc microglia was defined as 100%. Then p/T in all other non-phagocytosing and phagocytosing microglia was calculated as
percentage of p/T in non-phagocytosing control Con-Luc microglia. Average values ± SEM of three to five experiments, each performed in
duplicate or triplicate, are given. Significance of differences between initial values at 0 min and those at 10 and 30 min by one-way ANOVA and
the Dunnet’s post test are **p< 0.01 and ***p< 0.001 for Con-Luc microglia, and }p< 0.05 and }}}p< 0.001 for Syk-KD microglia. Significance of
difference between Con-Luc and Syk-KD microglia by two-way ANOVA and the Bonferroni post test are #p< 0.05 at 0 min and ###p< 0.001 at 30
min. (E and F) Phagocytosis by Syk-KD and control Con-Luc microglia after (E) 10 min and (F) 30 min of phagocytosis. Values of individual
experiments, each performed in triplicate, averages ± SEM, and levels of significance by double-tailed Mann-Whitney are given; ** p< 0.01.
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piceatannol inhibits Syk, PKA, PKC, and MLCK with
extremely close and also overlapping IC50 values (10, 3,
8, and 12 μM, respectively; Calbiochem). Therefore, it
is very likely that piceatannol reduced myelin phagocyt-
osis by inhibiting PKA, PKC, and MLCK alone or com-
bined. Of note, also others have questioned the
specificity of piceatannol towards Syk in some cell types
[38-40].
Cofilin regulates myelin phagocytosis
Cofilin-dependent regulation of myelin phagocytosis
is suggested by the findings that levels of phagocyt-
osis correlated positively with shifting the balance
from inactive p-cofilin to active cofilin (Figure 1).
First, control microglia displayed transient reduction
in p-cofilin levels during prolonged phagocytosis.
Second, microglia in which Syk was either inhibited
or its expression reduced displayed augmentation of
prolonged phagocytosis that was associated with a
continuous decrease in p-cofilin. Third, control and
Syk-KD microglia phagocytosed about the same at
times when both displayed similar levels of p-cofilin.
Cofilin could regulate myelin phagocytosis through
its ability to control remodeling of F-actin and
thereby production of membrane protrusions [26-
28]. This proposition is supported by our present
and previous observations. Live imaging in this study
revealed the involvement of filopodia-like membrane
protrusions in myelin phagocytosis. Additionally, we
demonstrated previously that remodeling of F-actin
localized preferentially to sites of myelin phagocyt-
osis, and, furthermore, that RhoA and its effector
ROCK downregulated CR3-mediated myelin phago-
cytosis by stabilizing F-actin [34] (see also Figure 1).
Syk down-regulates CR3-mediated myelin phagocytosis
by advancing the inactive phosphorylated state of
cofilin
Syk-dependent inactivation of cofilin is suggested by
current observations that p-cofilin levels decreased
when Syk activity and Syk expression were reduced.
It is unclear, and yet to be determined, how Syk
advanced the inactive phosphorylated state of cofilin
as it could promote phosphorylation and/or impede
dephosphorylation (Figure 1). To the best of our
knowledge, Syk-dependent regulation of cofilin acti-
vation has not been previously reported.
Finally, the concomitant occurrences of Syk-
dependent downregulation of CR3-mediated myelin
phagocytosis, Syk-dependent increase in p-cofilin,
and the negative correlation between phagocytosis
and p-cofilin levels all together suggest that Syk
downregulated phagocytosis by advancing the in-
active phosphorylated state of cofilin.
CR3 both activates and down-regulates myelin
phagocytosis
All together, our present and previous [30-33] observa-
tions reveal that CR3 both activated and downregulated
myelin phagocytosis, indicating that phagocytosis is
controlled by the balance between the two (see also
Figure 1). The dominance of activation over downregu-
lation was accomplished, at least in part, by a transient
decrease in p-cofilin levels. This transient decrease in
p-cofilin was Syk-dependent since reducing Syk activity
and expression resulted in a sustained decrease in
p-cofilin levels that was further associated with an
increase in phagocytosis.
Conclusions
Self-negative regulation of phagocytosis by the phagocytic
receptor can be useful in protecting phagocytes from ex-
cessive phagocytosis (i.e., “overeating”) during extended
exposure to particles that are destined for ingestion. In
our study, the phagocytic receptor was CR3 and the
ingested particles the tissue debris of degenerated myelin.
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